V2 Financial group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
+3,200
New +$221K 0.07% 130

Other funds holding XPH

V2 Financial group's XPH Position: Q3 2026 in Review

V2 Financial group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 3,200 shares worth $208K. The stake represents 0.07% of the portfolio and ranks #130 among its holdings.

117 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • V2 Financial group held 3,200 shares of State Street SPDR S&P Pharmaceuticals ETF worth $208K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new V2 Financial group position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.07% of V2 Financial group's portfolio in Q3 2026, its #130 holding.
  • 117 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on V2 Financial group's 13F filing for Q3 2026, filed 13 Nov 2026.